logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Healthcare Services
Filter

Healthcare Services

Categories

Sectors

Locations

Exchange

Everest Medicines

Lilly-Innovent Veteran to Head Everest Med; Commits to China Despite COVID-19

Feb 20, 2020

Life Science

新冠肺炎 中国 不可抗力 合同

Coronavirus outbreak in China spurs supply chain shifts that began during trade war

Feb 20, 2020

Life Science

康哲药业 CytoSorbents

CytoSorbents Enters Agreement with China Medical System Holdings Limited to Bring CytoSorb to Mainland China to Treat Critically-ill Patients with COVID-19 Coronavirus Infection

Feb 19, 2020

Life Science

北京安智因 融资

Anngeen Technolgies Raises $14 Million for Clinical Genetic Diagnosis Operations

Feb 19, 2020

Life Science

医疗保健精选——Co-Diagnostics盘前上涨8%,Meridian收购Exalenz Bioscience

Healthcare Roundup – Co-Diagnostics up 8% premarket, Meridian to acquire Exalenz Bioscience

Feb 19, 2020

Life Science

医疗保健精选——赛诺菲与BARDA合作研究冠状病毒疫苗,吉利德冠状病毒药物研究进展缓慢

Healthcare Roundup- Sanofi teams up with BARDA on coronavirus vaccine, Studies of Gilead coronavirus drug proceeding slowly  

Feb 18, 2020

Life Science

全国首个!海正药业法维拉韦获批治疗武汉新冠肺炎

Hisun Pharma’s Favilavir Approved to Treat Wuhan Coranovirus

Feb 18, 2020

Life Science

法国Stilla Technologies筹资2000万欧元,中国启迪控股参投

Stilla Technologies raises €20 million ($22 million) in Series B round that brings in new investor, TUS-Holdings, alongside existing ones

Feb 14, 2020

Life Science

三星Bioepis 仿制药

Samsung Bioepis OK’d to Start China Trial for Rare Disease Biosimilar

Feb 14, 2020

Life Science

医疗保健精选——世卫组织解释新的病毒病例后股价回升,幸福生物科技公司因冠状病毒爆发引发的需求而增长18%

Healthcare Roundup – Stocks recover after WHO explains new virus cases, Happiness Biotech up 18% on coronavirus outbreak-stoked demand

Feb 13, 2020

Life Science

爱格升和英迈中国合作,捐赠医疗推车抗击冠状病毒爆发

Ergotron and Ingram Micro Partner to Donate Medical Carts to Aid in Coronavirus Outbreak

Feb 12, 2020

Life Science

联络智能

Lianluo Smart Limited Announces Pricing of Approximately $2.2 Million Offering

Feb 12, 2020

Life Science

医疗保健精选——Vir Biotech识别冠状病毒结合抗体,FDA批准百特的代谢监测装置

Healthcare Roundup – Vir Biotech IDs coronavirus-binding antibodies, FDA clears Baxter metabolic monitoring device

Feb 12, 2020

Life Science

中国博瑞医疗成功仿制瑞德西韦,股价飙升

China’s BrightGene Replicates Remdesivir Antiviral API, Shares Hit the Ceiling

Feb 12, 2020

Life Science

医疗保健精选——强生与BARDA合作加速冠状病毒疫苗的开发;鲍威尔呼吁抵制对冠状病毒经济影响的猜测

Healthcare Roundup –J&J teams up with BARDA to accelerate coronavirus vaccine development; Powell urges resisting speculation on coronavirus economic effect

Feb 11, 2020

Life Science

医疗保健精选——美国冠状病毒病例有所增加,Moderna疫苗平台获得积极评论

Healthcare Roundup –Coronavirus cases inch up in U.S.; Moderna up 16% on positive comments on vaccine platform

Feb 7, 2020

Life Science

富士康等企业纷纷生产抗击冠状病毒口罩

Foxconn Hops Aboard Mask-Making Bandwagon

Feb 6, 2020

Life Science, Technology

医疗保健精选——Co-Diagnostics 展开冠状病毒RUO测试,美国财政部长姆钦希望很快了解病毒如何传播

Healthcare Roundup – Co-Diagnostics RUO test for coronavirus, Mnuchin expects more clarity in how virus spreads soon

Feb 6, 2020

Life Science

  • ‹‹ Previous
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada